TTP spinout Cellular Origins to focus on cell and gene therapies
TTP plc, a technology and product development company, has announced the launch of Cellular Origins. …
TTP plc, a technology and product development company, has announced the launch of Cellular Origins. …
BioAge Labs, Inc. has announced positive phase 1b clinical data for BGE-105, a highly selective,…
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
Biocartis will use its expertise in molecular diagnostics to produce a companion diagnostic test for…
Immatics has completed a $58M (€50M) round with the participation of Amgen, not long after both…
Elasmogen and its partner Feldan Therapeutics have signed a research agreement with Amgen to develop…
Amgen and Novartis have expanded their collaboration for the co-development of their migraine drug, ensuring…
Patrick Baeuerle is the German biotech leader I wanted to interview the most (besides Simon…
Immatics and Amgen have inked a deal to develop bispecific drug candidates for cancer that…
Genomics Medicine Ireland (GMI) has raised €36M ($40M) in series A to sequence the genome of…
The giant Amgen has offered Nuevolution €365M to develop oncology and neuroscience drugs. The small Danish…
Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian…